A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer

被引:44
作者
Bollineni, V. R. [1 ]
Kramer, G. [2 ]
Liu, Y. [1 ]
Melidis, C. [1 ]
deSouzac, N. M. [3 ,4 ]
机构
[1] European Org Res & Treatment Canc Headquarters, Brussels, Belgium
[2] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[3] Inst Canc Res, CRUK Canc Imaging Ctr, MRI Unit, Sutton SM2 5PT, Surrey, England
[4] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
关键词
Diffusion-weighted MRI; Apparent diffusion coefficient; Prostate cancer; Bladder cancer; Rectal cancer; Ovarian cancer; Cervical cancer; Endometrial cancer and tumour aggressiveness; POTENTIAL NONINVASIVE MARKER; CERVICAL-CANCER; HISTOGRAM ANALYSIS; GRADE; BIOMARKERS; PARAMETERS; CARCINOMA;
D O I
10.1016/j.ctrv.2015.03.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffusion-weighted magnetic resonance imaging (DW-MRI) is used extensively to improve tumour detection and localization because it offers excellent soft tissue contrast between malignant and non-malignant tissues. It also provides a quantitative biomarker; the apparent diffusion coefficient (ADC) can be derived from DW-MRI sequences using multiple diffusion weightings. ADC reflects the tumour microenvironment, e.g. cell membrane integrity and cellularity and has potential for reporting on tumour aggressiveness. This review focuses on the use of the DW-MRI derived imaging biomarker ADC to reflect tumour aggressiveness and its potential impact in managing pelvic cancer patients. The clinical studies which evaluate the role of ADC in pelvic turnouts (prostate, bladder, rectal, ovary, cervix and uterus) are summarized and the evidence linking ADC values with tumour aggressiveness is evaluated. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:496 / 502
页数:7
相关论文
共 42 条
[1]   Assessment of aggressiveness of rectal cancer using 3-T MRI: correlation between the apparent diffusion coefficient as a potential imaging biomarker and histologic prognostic factors [J].
Akashi, Michiaki ;
Nakahusa, Yuji ;
Yakabe, Tomomi ;
Egashira, Yoshiyuki ;
Koga, Yasuo ;
Sumi, Kenji ;
Noshiro, Hirokazu ;
Irie, Hiroyuki ;
Tokunaga, Osamu ;
Miyazaki, Kohji .
ACTA RADIOLOGICA, 2014, 55 (05) :524-531
[2]   Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations [J].
不详 .
NEOPLASIA, 2009, 11 (02) :102-125
[3]  
[Anonymous], UROL ONCOL
[4]  
[Anonymous], ABDOM IMAGING
[5]  
[Anonymous], ACTA RADIOL
[6]  
[Anonymous], ISRN RADIOL
[7]   Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer [J].
Bae, Hyeyeol ;
Yoshida, Soichiro ;
Matsuoka, Yoh ;
Nakajima, Hiroshi ;
Ito, Eisaku ;
Tanaka, Hiroshi ;
Oya, Miyako ;
Nakayama, Takayuki ;
Takeshita, Hideki ;
Kijima, Toshiki ;
Ishioka, Junichiro ;
Numao, Noboru ;
Koga, Fumitaka ;
Saito, Kazutaka ;
Akashi, Takumi ;
Fujii, Yasuhisa ;
Kihara, Kazunori .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (03) :555-561
[8]   Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement [J].
Bernardin, L. ;
Douglas, N. H. M. ;
Collins, D. J. ;
Giles, S. L. ;
O'Flynn, E. A. M. ;
Orton, M. ;
deSouza, N. M. .
EUROPEAN RADIOLOGY, 2014, 24 (02) :502-511
[9]   Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer [J].
Bharwani, N. ;
Miquel, M. E. ;
Sahdev, A. ;
Narayanan, P. ;
Malietzis, G. ;
Reznek, R. H. ;
Rockall, A. G. .
BRITISH JOURNAL OF RADIOLOGY, 2011, 84 (1007) :997-1004
[10]  
Bollineni VR, 2014, CHINESE CLIN ONCOL, V3, P1